A b s t r a c t -Among t h e r e t i n o i d s v i t a m i n A has an e x c e p t i o n a l p o s i t i o n b o t h b y volume and i n i t s f i e l d o f a p p l i c a t i o n . The competing t e c h n i c a l syntheses a r e discussed. The o t h e r r e t i n o i d s namely ( a l l g)-and (13 z)-R e t i n o i c a c i d and E t r e t i n a t e a r e used as t o p i c a l and systemic agents i n dermatology. Commercial s y n t h e t i c c a r o t e n o i d s a r e m a i n l y used as pigmenters f o r f o o d i n v i v o ; examples a r e egg y o l k -and b r o i l e r p i g m e n t a t i o n w i t h R-apo-8'-c a r o t e n o i c a c i d e t h y l e s t e r and p i g m e n t a t i o n o f f a r m -r a i s e d salmon w i t h a s t a x a n t h i n . Another f i e l d o f a p p l i c a t i o n i s d i r e c t c o l o r a t i o n o f food, e.g. o f margarine w i t h R-carotene. P r e s e n t l y R-carotene i s booming as a s u b s t i t u t e f o r v i t a m i n A w i t h o u t t e r a t o g e n i c p o t e n t i a l and as a b i o l o g ic a l a n t i o x i d a n t . Two s t r a t e g i e s compete i n manufacture o f these c a r o t e n o i ds -s y n t h e s i s o f R-apo-8'-carotenoids and O-carotene s t a r t i n g f r o m v i t a m i n A and i t s p r e c u r s o r s f o l l o w e d by t h e stepwise o x i d a t i o n o f R-carotene t o c a n t h a x a n t h i n and a s t a x a n t h i n -c o n v e r s i o n o f 0x0-isophorone t o C o x i d a t i o n p a t t e r n i n t h e R -i o n o n e l F i n g f o l l o w e d by W i t t i g condensation w i t h ClO-dialdehyde.
R e t i n o i c a c i d and E t r e t i n a t e a r e used as t o p i c a l and systemic agents i n dermatology. Commercial s y n t h e t i c c a r o t e n o i d s a r e m a i n l y used as pigmenters f o r f o o d i n v i v o ; examples a r e egg y o l k -and b r o i l e r p i g m e n t a t i o n w i t h R-apo-8'-c a r o t e n o i c a c i d e t h y l e s t e r and p i g m e n t a t i o n o f f a r m -r a i s e d salmon w i t h a s t a x a n t h i n . Another f i e l d o f a p p l i c a t i o n i s d i r e c t c o l o r a t i o n o f food, e.g. o f margarine w i t h R-carotene. P r e s e n t l y R-carotene i s booming as a s u b s t i t u t e f o r v i t a m i n A w i t h o u t t e r a t o g e n i c p o t e n t i a l and as a b i o l o g ic a l a n t i o x i d a n t . Two s t r a t e g i e s compete i n manufacture o f these c a r o t e n o i ds -s y n t h e s i s o f R-apo-8'-carotenoids and O-carotene s t a r t i n g f r o m v i t a m i n A and i t s p r e c u r s o r s f o l l o w e d by t h e stepwise o x i d a t i o n o f R-carotene
t o c a n t h a x a n t h i n and a s t a x a n t h i n
-c o n v e r s i o n o f 0x0-isophorone t o C o x i d a t i o n p a t t e r n i n t h e R -i o n o n e l F i n g f o l l o w e d by W i t t i g condensation w i t h ClO-dialdehyde.
-phosphonium s a l t s o f d i f f e r e n t
INTRODUCTION T h i s r e p o r t d e a l s w i t h t h e r e t i n o i d s and c a r o t e n o i d s w h i c h a r e c u r r e n t l y c o m m e r c i a l l y a v a i l a b l e . I t i s i n t h e n a t u r e o f t h i n g s t h a t i n f o r m a t i o n on
t h e s e cannot be v e r y a c c u r a t e o r complete. The m a n u f a c t u r e r s o f these p r o d u c t s a r e c o m p e t i t o r s and t h u s n o t i n t e r e s t e d i n r e v e a l i n g d e t a i l s o f syntheses o r c a p a c i t i e s and m a n u f a c t u r i n g c o s t s . 
The two groups o f p r o d u c t s t o be d e a l t w i t h a r e summarized i n F i g . 1 and 2. I n t o t a l , f o u r r e t i n o i d s and s i x s y n t h e t i c c a r o t e n o i d s have t o d a t e become o f commercial importance. P-Apo-E'-Carotenal (C30)
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Among t h e r e t i n o i d s , v i t a m i n A occupies a s p e c i a l p o s i t i o n . I t i s t h e most i m p o r t a n t p r o d u c t i n terms o f q u a n t i t y s o l d . V i t a m i n A i s m a i n l y used i n t h e feed-and f o o d s t u f f s s e c t o r : i t ensures t h a t l i v e s t o c k t h r i v e and i n c r e a s e s t h e i r r e s i s t a n c e t o i n f e c t i o u s diseases ( r e f . 1 ) .
The o t h e r r e t i n o i d s a r e used i n p h a r m a c e u t i c a l s and employed i n dermatology ( r e f . 2 ) .
The main r e a s o n f o r p r o d u c i n g t h e c a r o t e n o i d s i s f o r t h e i r c o l o r i n g p r o p e r t i e s ; t h e y a r e used on t h e one hand f o r d i r e c t c o l o r i n g o f f o o d s t u f f s and, on t h e o t h e r hand, f o r pigment a t i o n o f animal p r o d u c t s b y a d m i n i s t r a t i o n i n t h e f e e d ( r e f . 3 ) . I n a d d i t i o n , i t i s beco-
ming i n c r e a s i n g l y e v i d e n t t h a t t h e c a r o t e n o i d s have i m p o r t a n t r o l e s i n t h e animal and human body, b e s i d e s t h e i r p r o v i t a m i n A a c t i v i t y ( r e f . 4).
VITAMIN A
Three companies a r e c u r r e n t l y m a r k e t i n g v i t a m i n A -Hoffmann-La-Roche, BASF AG and A.E.C.
Rh6ne-Poulenc, and t h e y produce about 3000 tonnes o f t h i s v i t a m i n i n t o t a l each y e a r . I n t h e f o r m o f a 15 % d i s p e r s i b l e powder i n which i t i s u s u a l l y s o l d , 1 k g o f v i t a m i n A p r e s e n t l y c o s t s about US $ 120. The s a l e s world-wide a r e t h e r e f o r e about US $ 360 m i l l i o n ,
The syntheses used b y t h e t h r e e manufacturers d i f f e r f i r s t i n t h e b a s i c chemicals used t o s y n t h e s i z e pseudoionone and 6-ionone, secondly i n t h e t y p e o f i n t e r m e d i a t e s used f o r c h a i n e x t e n s i o n and f i n a l l y i n t h e method o f l i n k a g e employed t o g i v e t h e Cz0 f i n a l p r o d u c t . --OH DH-Linalool ((210) Vlonone ( 5, 6 ) . Both p r ec u r s o r s can be s y n t h e s i z e d i n s e v e r a l s t e p s f r o m b a s i c chemicals, w i t h s i g m a t r o p i c r earrangements p l a y i n g a c r u c i a l p a r t ( F i g . 3 ) . A f a s c i n a t i n g example i s t h e double Cope rearrangement o f t h e d i e n o l e t h e r t h a t i s produced by a c e t a l i z a t i o n and e l i m i n a t i o n f r o m 3-methylbutenal ( F i g . 4, r e f . 7 ) .
The C6 and C c h a i n o f c a r 8 t e n o i d s . The b a s i c chemicals f o r t h e C6 u n i t a t Hoffmann-La-Roche a r e methyl u n i t s employed f o r c h a i n e x t e n s i o n a r e a l s o used t o b u i l d up t h e polyene v i n y l ketone and acetylene ( r e f . 8 ) . The C 3-methyl-1-butyn-3-01 v i a 3-methyl-2-buten2-l-al ( r e f . 9). A t BASF t h e C acetate i s obt a i n e d by hydroformylation o f 1-butenediol d i a c e t a t e ( F i g . 5, r e f . 10) 09 by a synthesis based on oxirane and a c e t i c a c i d v i a acetoxyacetaldehyde and condensation w i t h propanal ( r e f . 11). S e l e c t i v e a l d o l condensations o f t h i s type g i v e y i e l d s around 70 % i n the presence of equimolar amounts o f dimethylamine and a c e t i c acid; t h e c a t a l y s t system can be r ecycled.
The polyene c h a i n must be b u i l t up under p a r t i c u l a r l y m i l d c o n d i t i o n s . Hoffmann-La-Roche and Rh6ne-Poulenc achieve t h i s by a d d i t i o n and e l i m i n a t i o n , t h e former by l i n k i n g C C 13). A t BASF AG, C15 i s j o i n e d t o C5 i n a one-step W i t t i g r e a c t i o n ( r e f . 14,lFig. 6 ) .
u n i t used by Rh6ne-Poulenc i s prepared from and i n a Grignard r e a c t i o n ( r e f . 12) and t h e l a t t e r by J u l i a -s y n t h e s i s from C and 6; ( r e f . Vitamin A syntheses based on the C economic importance as y e t ( r e f . 18). This s g n t h e t i c approach i s mentioned here neverthel e s s , because t h e Cg + C6 s t r a t e g y has proven very u s e f u l i n carotenoid syntheses. The retinoids which have been approved t o date are synthesized i n substantially the same way as vitamin A (Fig. 8 , r e f . 2 2 ) . For example, ( a l l !)-and (13 I ) -r e t i n o i c acid are obtained straightforwardly and in good yields from the C phosphonium s a l t a n d C -aldehyde e s t e r s or the appropriate C -1actol. The oxidation of @tiny1 acetate t o retino7c acid with s i l v e r oxide has been descr7bed and i s preferred by manufacturers who do n o t have the C15 and C5 units available ( r e f . 23). 
prospects of t h i s have recently led t o a considerable i n t e n s i f i c a t i o n of research in t h i s area. The main problems associated with t h i s
are well known i n pharmaceutical research, namely (1) -Selection of actions from the almost bewildering variety displayed by retinoids. These include e f f e c t s on c e l l d i f f e r e n t i a t i o n , c e l l p r o l i f e r a t i o n , sebum production and keratinization, in addition t o immunostimulation, antiinflammatory e f f e c t s and morphogenic a c t i v i t i e s ( 2 ) -Improvement of the therapeutic index by reducing undesired side e f f e c t s , in particular reduction of the potential f o r i r r i t a t i o n on topical application and reduction of the teratogenicity on systemic adminis t r a t i o n . With the a v a i l a b i l i t y of water-soluble 8-glucuronide derivatives, problems of formulation and of absorption and transport of retinoids are overcome ( r e f . 2 4 ) . Pelretin, which i s a phenyl analog, has been shown i n c l i n i c a l t e s t s t o have a particularly low potential f o r i r r i t a t i o n ( r e f . 25). The tetramethyltetralin derivatives are expected t o have the most favorable spectrum of action t o date f o r the treatment of sun-damaged skin ( r e f . 26).
Research i n t o these questions now even extends i n t o molecular biology. There i s intensive investigation of the e f f e c t s of retinoids on gene expression. Various retinoic acid recept o r s have been i d e n t i f i e d , and i t i s now possible t o synthesize retinoids t h a t are designed t o f i t these ( r e f . 2 7 ) .
C a r o t e n o i d s y n t h e s i s i s s t i l l t h e p r e s e r v e o f Hoffmann-La-Roche and BASF AG, where v i t a m i n A i s manufactured, p a r t l y because f r o m t h e o u t s e t t h e s e companies had t h e r e q u i r e d range o f
p r e c u r s o r s and e x p e r i e n c e i n s y n t h e s i z i n g polyene c h a i n s . Both companies i n i t i a l l y concent r a t e d on c o n s t r u c t i n g t h e r e l a t i v e l y l a r g e t a r g e t molecules by u s i n g carbon-carbon l i n k a g e methods t h a t were a l r e a d y proven i n v i t a m i n A c h e m i s t r y ; these were, i n p a r t i c u l a r , ( 1 ) a t Hoffmann-La-Roche, G r i g n a r d syntheses and e n o l e t h e r condensations ( r e f . 9, 28) and ( 2 ) a t BASF AG, e t h y n y l a t i o n s and W i t t i g o l e f i n syntheses ( r e f . 12, 1 4 ) . t h i s t y p e o f s y n t h e t i c s t r a t e g y p e r m i t s t h e processes t o be s i m p l i f i e d and makes m u l t i s t a g e syntheses economical.
B-APO-CAROTENOIDS
The s t r a t e g y i s e v i d e n t i n t h e p r e p a r a t i o n o f t h e O-apo-8'-carotenoids and O-carotene. The s y n t h e s i s o f O-apo-8'-carotenal a t Hoffmann-La-Roche s t a r t s f r o m t h e C g i v e s , i n two e n o l e t h e r condensations, t h e C u n i t i Syntheses based on t h e C + C unsymmetrical C geous t o p r e p a d o t h e B-apo-8'-carotenoids v i a B -a p o -l Z ' -c a r o t e n a l . Three e q u a l l y e f f i c i e n t pathways have been developed f o r t h e s y n t h e s i s o f t h i s i n t e r m e d i a t e . These a r e W i t t i g r e a ct i o n s o f ( 1 ) C symmetrical C 1 5 d i a l d e h y d e ( r e f . 32), ( 2 ) C a c e t a l ( r e f . ig, F i g . 11) and ( 3 ) r e t i n a l @ t h t h e c o r r e s p o n d i n g C ( r e f . 34 F i g . 1 2 ) . R e t i n a l i s o b t a i n e d e i t h e r by dehydrogenation o? r e t i n o l w i t h oxygen and TEMPO/Cu C1 as c a t a l y s t ( r e f . 35) o r by W i t t i g r e a c t i o n o f t h e C another i e l 6 c t i v e l y p r o t e c t e d C5 dialdehyde, 3-methyl-butenedial-~~acetal ( r e f . 33, F i g . 12) The C aldehyde and C e t h y l e s t e r t a r g e t compounds a r e o b t a i n e d f r o m t h e C W i t t i 8 O r e a c t i o n w i t h t?$ C5 phosphonium s a l t ( r e f . 34) o r w i t h an a p p r o p r i a t e 2 t 5 e t h y l e s t e r phosphonate ( r e f . 36).
t C W i t t i g r e a c t i o n s ; b o t h companies have phospho-
scheme appear s h o r t and e l e g a n t , b u t t h e p r e p a r a t i o n o f t h e fragmeaes is18 m u l t i s t a g e and t h u s c o s t l y process. I t i s t h e r e f o r e advantaphosphonium s a l t o f t h e v i t a m i n A s y n t h e s i s w i t h one e q u i v a l e n t o f t h e phosphonium s a To complete t h e group o f 8-apo-carotenoids o f commercial i n t e r e s t , t h e s y n t h e s i s o f t h e C ketone c i t r a n a x a n t h i n s h o u l d be mentioned b r i e f l y . I t i s produced i n about 90 % y i e l d f r o $ 8 -a p o -8 ' -c a r o t e n a l by a l d o l condensation w i t h acetone ( r e f . 3 9 ) .
l t w i t h 2 -m e t h y l -b u t e n e d i a l -lphosphonium c h l o r i d e phosphonium s a l t w i t h aldehyde by
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F i g . 11 and 12. R e t i n a l and 8-apo-12'-carotenal i n t h e s y n t h e s i s o f O-apo-8'-carotenoids
C5-INTERMEDIATES
3-Methyl-butenedial-1-acetal i s e a s i l y o b t a i n e d i n two stages v i a g l y o x a l monoacetal by s e l e c t i v e a l d o l condensation w i t h propanal ( r e f . 33).
The C e s t e r component i s o b t a i n e d f r o m 4-bromo-2-methyl-2-butenoic a c i d e t h y l e s t e r and t r i e t 8 y l p h o s p h i t e . The bromo-ester i t s e l f i s s y n t h e s i z e d ( 1 ) f r o m methyl v i n y l ketone and h y d r o c y a n i c a c i d v i a 2-methyl-2-hydroxy-3-butenoic a c i d e t h y l e s t e r ( r e f . 37) by r e a c t i o n w i t h phosphorous t r i b r o m i d e o r ( 2 ) f r o m 2 -m e t h y l -3 -b u t e n o n i t r i l e v i a t h e e t h y l e s t e r by a d d i t i o n o f bromine and e l i m i n a t i o n o f hydrogen bromide ( r e f . 38). I t i s p a r t i c u l a r l y economical t o p r e p a r e a l l t h e C5 components f r o m t h e C5 a c e t a t e i n t e rmediate t h a t i s used i n t h e v i t a m i n A process ( F i g . 1 3 ) . O x i d a t i o n of t h e C a c e t a t e w i t h p e r s u l f u r i c a c i d i n e t h a n o l g i v e s 4-hydroxy-2-methyl-2-b u t e n o i c a c i d e t h y ? e s t e r i n 80 % y i e l d . T h i s i s c o n v e r t e d t o t h e C5 e t h y l e s t e r phosphonate i n an o b v i o u s way.
The C a l c o h o l o b t a i n e d by a c e t a l i z a t i o n w i t h a 1 , 3 -d i o l and e s t e r h y d r o l y s i s can be convert e d b$ r e a c t i o n w i t h phosgene and t r i p h e n y l phosphine i n t o t h e C5 phosphonium c h l o r i d e i n 80 % o v e r a l l y i e l d .
2-Methyl-butenedial-1-acetal i s o b t a i n e d by dehydrogenation o f t h e C a l c o h o l w i t h oxygen and t h e TEMPO/Cu C1 v e r t e d i n t o t h e i l d g h y d e s i n t h i s way ( r e f . 35). On W i t t i g r e a c t i o n w i t h t h e C phosphonium c h l o r i d e and h y d r o l y s i s t h e new C5 aldehyde g i v e s a 90 % y i e l d o f t h e symmetrizal Cl0 d i a l d ehyde which i s t h e c e n t r a l p a r t o f many C40 c a r o t e n o i d s . c a t a l y s t i n 90 % y i e l d . Other polyene a l l y l i c a?cohols can a l s o be con-
As t h e name i n d i c a t e s , t h e 8-apo-carotenoids a r e formed by o x i d a t i v e d e g r a d a t i o n o f t h e C40 c a r o t e n o i d s , e s p e c i a l l y o f 8-carotene. As such t h e y have always been p r e s e n t i n o u r f o o d
and t h u s t h e y a r e a b s o l u t e l y n o n -t o x i c i n t h e n a t u r a l c o n c e n t r a t i o n s . They are, t h e r e f o r e , h i g h l y s u i t a b l e n a t u r a l c o l o r a n t s f o r foods ( r e f . 1, 3 ) . 8-Apo-C e s t e r ( r e f . 40) and c i t r a n a x a n t h i n a r e used i n t h e p i g m e n t a t i o n o f egg y o l k s and bro??ers, e s p e c i a l l y when t h e f e e d s t u f f s c o n t a i n few n a t u r a l x a n t h o p h y l l s . 
8-Apo-C aldehyde i s used f o r d i r e c t c o l o r i n g o f f o o d s t u f f s , e s p e c i a l l y cheese. The t o t a l s a l e s o f 3 ? h i s group o f p r o d u c t s arenow about US $ 50 m i l l i o n .
P-CAROTENE
6-Carotene has been produced by Hoffmann-La Roche s i n c e 1954 and by BASF s i n c e 1972. As w i t h t h e D-apo-carotenoids, t h e syntheses o f 8-carotene i n b o t h companies l e a n h e a v i l y on t h e range o f v i t a m i n
Hoffmann-La Roche l i n k e d 2 moles o f t h e C a c e t y l e n e bis(magnesium h a l i d e ) and o b t a i h g d B-carotene a f t e r p a r t i a l hydrogenation and a c i d -c a t a l y z e d e l i m i n a t i o n o f 2 moles o f water ( r e f . 41). BASF AG l i n k e d two moles o f t h e C c a l C vitamA8 A ( F i g . 15, r e f . 43). B o t h r o u t e s have been u s e d 2 ? n d u s t r i a l l y , depending on t h e a v a i l a b i l i t y o f t h e p r e c u r s o r s , and, a f t e r thermal i s o m e r i z a t i o n , p r o v i d e d c r y s t a l l i n e ( a l l --E)-B-carotene
t r e s u l t s 2 % e o b t a i n e d w i t h p o t a s s i u m carbonate and hydrogen p e ro x i d e i n w a t e r a t ambient temperature. Removal o f t r i p h e n y l p h o s p h i n e o x i d e by e x t r a c t i o n and t h e r m a l i s o m e r i z a t i o n r e s u l t i n a n a l y t i c a l l y p u r e O-carotene i n y i e l d s o f around 80 % ( r e f . 4 6 ) . aldehyde w h i c h has a l r e a d y been mentioned w i t h phosphonium s a l
F i g . 16. T e c h n i c a l s y n t h e s i s o f B-carotene
There i s an economic advantage i n t h e use o f t h e C phosphonium s a l t i n t h e s y n t h e s i s O f c a r o t e n o i d s ( F i g . 1 6 ) : c r y s t a l l i z a t i o n o f ( a l l E ) -@ t i n y 1 a c e t a t e l e a d s t o mother l i q u o r which c o n t a i n s c o n s i d e r a b l e q u a n t i t i e s o f (J/L)zisorneric v i t a m i n A compounds. These become u s e f u l o n l y a f t e r t h e y have been c o n v e r t e 8-Carotene i s always p r e s e n t i n c h l o r o p h y l l -c o n t a i n i n g p l a n t s and i s t h u s t h e most w i d e l y d i s t r i b u t e d c a r o t e n o i d . I t s r o l e as a c o f a c t o r i n p h o t o s y n t h e s i s i s now w e l l understood. Carotenoids and, i n p a r t i c u l a r , 8-carotene appear t o c a r r y o u t f u n c t i o n s i n animals and humans w h i c h go f a r beyond a c t i n g as an o p t i c a l s i g n a l and h a v i n g p r o v i t a m i n A a c t i v i t y . F o r example, O-carotene enhances immunity and a c t s as an i n t r a c e l l u l a r a n t i o x i d a n t t o supplement t o c o p h e r o l w h i c h m a i n l y a c t s i n t h e c e l l membrane ( r e f . 4 ) . These f i n d i n g s p o i n t t o i m p o r t a n t new uses o f B-carotene, e s p e c i a l l y s i n c e i t i s e n t i r e 
d w i t h t r i p h e n y l p h o s p h i n e and s u l f u r i c a c i d i n t o t h e phosphonium s a l t , m a i n l y because i t i s t h e n p o s s i b l e t o remove i m p u r i t i e s s t r a i g h t f o rw a r d l y by washing w i t h n o n p o l a r s o l v e n t s . The c o s t s o f raw m a t e r i a l s f o r D-carotene a r e t h e r e f o r e determined e s s e n t i a l l y by t h e p r i c e o f t r i p h e n y l p h o s p h i n e ; B-carotene has t h u s become t h e l o w e s t -c o s t c a r o t e n o i d .
When W i t t i g o l e f i n syntheses a r e c a r r i e d o u t on t h e i n d u s t r i a l
n e . I t i s l i k e l y t h a t R-carotene w i l l soon o v e r t a k e v i t a m i n A. C a p a c i t y f o r more t h a n 500 tonnes o f R-carotene p e r y e a r i s c u r r e n t l y planned o r under c o n s t r u c t i o n w o r l dwide. R-Carotene s a l e s may r e a c h US $ 500 m i l l i o n towards t h e end o f t h i s c e n t u r y . T o t a l s a l e s o f s y n t h e t i c c a r o t e n o i d s a r e a l r e a d y i n t h e o r d e r o f US $ 300 M i l l . and may pass t h e US $ 500 m i l l i o n mark i n o n l y about 5 y e a r s .
THE DEVELOPMENT OF CANTHAXANTHIN AND ASTAXANTHIN
I n t h e 1950s i t was d i s c o v e r e d a t Hoffmann-La-Roche t h a t some o f t h e c a n t h a x a n t h i n added t o c h i c k e n feed i s d e p o s i t e d i n t h e egg y o l k ( r e f . 5 0 ) . Together w i t h t h e x a n t h o p h y l l s which a r e n a t u r a l l y p r e s e n t o r w i t h B-apo-C e s t e r , c a n t h a x a n t h i n g i v e s t h e egg y o l k an oranger e d c o l o r w h i c h many consumers l i k e . ? $ r o t e n o i d s i n t h e f e e d a r e a l s o d e p o s i t e d i n t h e b o d i e s of p o u l t r y , b e i n g e v i d e n t i n t h e comb, beak and l e g s . T h i s i s n o t s i m p l y a cosmetic e f f e c t . I t i s now known t h a t c a r o t e n o i d s enhance r e s i s t a n c e t o diseases and improve t h e s h e l f l i f e and h a t c h a b i l i t y o f eggs.
Commercial processes f o r t h e p r e p a r a t i o n o f c a n t h a x a n t h i n a r e based on t h e o x i d a t i o n o f D-carotene and a r e t h u s developments o f t h e v e r y e a r l y i n v e s t i g a t i o n s by Zechmeister and K a r r e r ( F i g . 17, r e f . 5 1 ) . The p r i n c i p l e i s t h a t R-carotene i s halogenated i n p o s i t i o n 4 and then, v i a i n t e r m e d i a t e s f r o m s o l v o l y s i s r e a c t i o n s , o x i d i z e d t o c a n t h a x a n t h i n . I n o u r v a r i a n t o f t h e process, R-carotene i s o x i d i z e d w i t h sodium c h l o r a t e i n t h e presence o f c a t a l y t i c amounts o f i o d i n e . Y i e l d s o f about 65 X o f i s o l a t e d ( a l l E ) -c a n t h a x a n t h i n a r e o b t a i n e d i n a dichloromethane/-water two-phase system ( r e f . 5 2 ) .
Canthaxanthin ( C~O ) 0 F i g . 17. S y n t h e s i s o f c a n t h a x a n t h i n by C I~C H~/ H~O , P H~
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-p-Carotene (C40)
Hoffmann-La-Roche subsequently took t h e i n i t i a t i v e and s y n t h e s i z e d c a n t h a x a n t h i n by t h e t r i e d and t e s t e d C t C t C scheme ( F i g . 18, r e f . 5 3 ) . The n o v e l 3-0x0-c phosphonium s a l t can be p r e p a r 8 by LRe C 15t C r o u t e s . I n b o t h cases, t h e ch8ponents a r e l i n k e d by a d d i t i o n o f an orgah&neta?lic coipouns t o a c a r b o n y l group. The C obtained, f o r example, by s e l e c t i v e r e d u c t i o n o f t h e 4-0x0 group t o 4-hydro?y-6-oxo-isophor o n e ( r e f . 54); c a n t h a x a n t h i n y i e l d s o f around 80 % a r e o b t a i n e d f r o m r e a c t i o n o f t h e CI5 y l i d e w i t h t h e Cl0 d i a l and t h e i n t e r m e d i a t e CZ5 aldehyde. and C t C u n i t can be C15 t Cl 0 + C15 S y n t h e s i s o f c a n t h a x a n t h i n a~t a x a n t h i h~a n d
.@axani$in I t i s known t h a t wild salmon acquire astaxanthin and i t s e s t e r s from t h e i r food and s t o r e the pigment i n t h e i r t i s s u e s . As aquaculture, e s p e c i a l l y of salmon, has i n t e n s i f i e d in r e c e n t y e a r s , there has been a rapid increase i n i n t e r e s t i n t h i s carotenoid ( r e f . 5 5 ) .
Synthetic astaxanthin has been marketed only by Hoffmann-La-Roche t o d a t e , and t h i s company i s responsible f o r a l l s e r i o u s approaches t o the s y n t h e s i s of t h i s carotenoid.
Astaxanthin can, i n p r i n c i p l e , be obtained by oxidation of o t h e r C40 carotenoids, f o r examp l e from canthaxanthin by preparing the b i s -s i l y l enol e t h e r and oxidizing t h i s with peracid ( F i g . 19, r e f . 56, 5 9 ) . The p r o t e c t i v e groups prevent f u r t h e r oxidation t o astacene.
Commercial astaxanthin s y n t h e s i s uses t h e f a m i l i a r C + C t C scheme. The C u n i t i s once again produced by t h e C t C r o u t e , and t h e Cg12cetoh?de ik5synthesized in'?.hree s t r a i g h t f o r w a r d s t e p s from o,?o-isgphorone ( r e f . 5 7 ) . The same p r i n c i p l e i s used, v i a a C9 u n i t prepared by fermentation, t o synthesize (3&3'R)-zeaxanthin ( F i g . 20, r e f . 5 8 ) .
SYNTHETIC STRATEGIES
To summarize, t h e r e appear t o be two fundamentally d i f f e r e n t s t r a t e g i e s f o r the s y n t h e s i s of these carotenoids ( F i g . 21 and 2 2 ) . On the one hand, B-carotene can be synthesized from vitamin A and triphenylphosphine and then oxidized s p e c i f i c a l l y t o canthaxanthin and a s t axanthin. On t h e o t h e r hand, i t i s p o s s i b l e t o prepare a s p e c i f i c trimethylcyclohexanone f o r each carotenoid ( r e f . 5 9 ) . Alkylation w i t h the C component and conversion of the C u n i t i n t o the phosphonium s a l t can be followed by Witpig r e a c t i o n w i t h t h e Cl0 dialdehydi t o give t h e f i n a l products. This s t r a t e g y i s a t t r a c t i v e because i t i s self-contained and, i n princ i p l e , a l s o permits t h e s y n t h e s i s o f vitamin A and the e s s e n t i a l vitamin E precursor trimethylhydroquinone ( r e f . 6 0 ) .
The two s y n t h e t i c approaches allow c e r t a i n conclusions t o be drawn about t h e c o s t s of manuf a c t u r i n g t h e s e carotenoids. I t i s possible t o deduce from t h e " v e r t i c a l " scheme t h a t , although B-carotene should be a c c e s s i b l e a t very low c o s t from vitamin A , t h e more highly oxygenated carotenoids must be i n c r e a s i n g l y c o s t l y . By c o n t r a s t , the " h o r i z o n t a l " scheme s t a r t i n g from 0x0-isophorone i s expected t o have comparable c o s t s of manufacture of t h e i ndividual carotenoids a t comparable l e v e l s of production.
